Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
Arkansas Children's Hospital, Little Rock, Arkansas University of Arkansas for Medical Sciences, Little Rock, Arkansas Yale-New Haven Hospital, New Haven, Connecticut BayCare Health System-St. Joseph's Women's Hospital, Tampa, Florida NorthShore University-Evanston Hospital, Evanston, Illinois Oklahoma Children's Hospital, Oklahoma City, Oklahoma Penn State Health Milton S Hershey Medical Center/Penn State University College of Medicine, Hershey, Pennsylvania University of Pittsburgh Medical Center Magee Womens Hospital, Pittsburgh, Pennsylvania